138 related articles for article (PubMed ID: 2880275)
1. [Neuroleptic parkinsonism].
Izakson KhA
Med Sestra; 1986 Sep; 45(9):50-2. PubMed ID: 2880275
[No Abstract] [Full Text] [Related]
2. Selegiline for neuroleptic-induced parkinsonism.
Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
[No Abstract] [Full Text] [Related]
3. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
Hausner RS
J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced Parkinson`s disease. A clinical review.
Bohlega SA; Al-Foghom NB
Neurosciences (Riyadh); 2013 Jul; 18(3):215-21. PubMed ID: 23887211
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic rounds: neuroleptic malignant syndrome.
Schulz P; Dick P
Clin Ther; 1986; 8(6):605-6, 722-3. PubMed ID: 2878725
[No Abstract] [Full Text] [Related]
6. [Is the glabellar reflex a component of neuroleptic-induced Parkinsonism?].
Sánchez R; Calvo JM; Jaramillo LE
Biomedica; 2005 Dec; 25(4):539-46. PubMed ID: 16433181
[TBL] [Abstract][Full Text] [Related]
7. The effect of amantadine on neuroleptic-induced parkinsonism.
Rüther E; Fussmann-Hegewald M; Eben E
Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089
[No Abstract] [Full Text] [Related]
8. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
Peschel O; Kurtz G; Müller-Felber W; Modell S
Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Bitton V; Melamed E
J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced parkinsonism].
Kuzuhara S
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):29-31. PubMed ID: 10434583
[No Abstract] [Full Text] [Related]
11. Neuroleptic-induced parkinsonism: impaired potentiation of the H-reflexes.
Bartels M; Maltzahn DV; Mezger G
Electromyogr Clin Neurophysiol; 1982; 22(1-2):9-20. PubMed ID: 6121699
[No Abstract] [Full Text] [Related]
12. The diagnosis and treatment of neuroleptic-induced Parkinsonism.
Hoffman BF
Hosp Community Psychiatry; 1981 Feb; 32(2):110-4. PubMed ID: 6115811
[TBL] [Abstract][Full Text] [Related]
13. Akathisia: a distressing complication of neuroleptic treatment.
Szabadi E
Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560
[No Abstract] [Full Text] [Related]
14. Critique of DSM-IV: associated features of neuroleptic-induced parkinsonism.
Segraves T; Abdel-Dayem M
Am J Psychiatry; 1996 Jun; 153(6):844. PubMed ID: 8633713
[No Abstract] [Full Text] [Related]
15. Seborrheic dermatitis: a newly reported side effect of neuroleptics.
Binder RL; Jonelis FJ
J Clin Psychiatry; 1984 Mar; 45(3):125-6. PubMed ID: 6142036
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced parkinsonism.
Lancet; 1985 Jan; 1(8420):113. PubMed ID: 2857014
[No Abstract] [Full Text] [Related]
17. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
Rondot P; Bathien N
Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
[No Abstract] [Full Text] [Related]
18. Treatment of acute neuroleptic-induced movement disorders.
Tonda ME; Guthrie SK
Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
[TBL] [Abstract][Full Text] [Related]
19. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
Binder RL; Jonelis FJ
Arch Dermatol; 1983 Jun; 119(6):473-5. PubMed ID: 6134496
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.
Chouinard G; Annable L; Mercier P; Turnier L
Psychopharmacol Bull; 1987; 23(1):221-6. PubMed ID: 2885889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
